Doximity (NASDAQ:DOCS – Get Free Report) will announce its earnings results after the market closes on Thursday, May 16th. Analysts expect the company to announce earnings of $0.20 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.
Doximity (NASDAQ:DOCS – Get Free Report) last issued its earnings results on Thursday, February 8th. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.19 by $0.06. Doximity had a net margin of 29.39% and a return on equity of 16.08%. The company had revenue of $135.28 million for the quarter, compared to the consensus estimate of $127.46 million. On average, analysts expect Doximity to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Doximity Stock Performance
Shares of NASDAQ:DOCS opened at $23.89 on Thursday. Doximity has a 52 week low of $19.71 and a 52 week high of $36.29. The company’s fifty day moving average is $26.30 and its 200-day moving average is $26.35. The company has a market capitalization of $4.46 billion, a PE ratio of 36.92, a P/E/G ratio of 3.03 and a beta of 1.18.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on DOCS
Insider Buying and Selling
In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $26.97, for a total value of $67,425.00. Following the transaction, the director now directly owns 10,258 shares of the company’s stock, valued at $276,658.26. The sale was disclosed in a legal filing with the SEC, which is available through this link. 39.40% of the stock is owned by insiders.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Recommended Stories
- Five stocks we like better than Doximity
- Energy and Oil Stocks Explained
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- How to Capture the Benefits of Dividend Increases
- Generac Powers Ahead on the Electrification Mega-Trend
- Find and Profitably Trade Stocks at 52-Week Lows
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.